Tai-chung -. Tseng
7 Chung Shan South Road
TPQ 10002, Taiwan
TPQ 10002, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 170 publications
HBV RNA, HBcrAg, and HBsAg levels at year 6 do not predict HCC risk in patients with cirrhosis on long-term entecavir therapy.
Journal: Hepatology international
Published: June 09, 2026
Long-Term Liver Outcomes in Wilson's Disease: Predictors of Survival and Hepatocellular Carcinoma.
Journal: Clinical and molecular hepatology
Published: April 01, 2026
Refining surveillance of hepatocellular carcinoma in chronic hepatitis B through biomarker-based risk stratification.
Journal: Hepatology communications
Published: October 22, 2025
Reply: HBV DNA level of genuine immune-tolerant patients.
Journal: Hepatology (Baltimore, Md.)
Published: September 30, 2025
Serum Mac-2 binding protein glycosylation isomer in predicting hepatocellular carcinoma occurrence among patients with direct-acting antiviral-induced HCV cure.
Journal: Scientific reports
Published: September 14, 2025
Reply: Prevalence of serum HBsAg <100 IU/mL in inactive chronic hepatitis B.
Journal: Gut
Published: September 11, 2025
Predictive Value of Serum Mac-2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus-Infected Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
Journal: Journal of gastroenterology and hepatology
Published: September 03, 2025
Effect of Glycated Hemoglobin Levels on Serum Mac-2 Binding Protein Glycosylation Isomer in the Diagnosis of Hepatitis C-Virus Related Hepatic Fibrosis.
Journal: Journal of medical virology
Published: August 31, 2025
Molecular Milestones and Survival Outcomes of Ponatinib Treatment in Patients With Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: A Real-World Analysis.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 06, 2025
Last Updated: 09/26/2026